Amyotrophic Lateral Sclerosis Clinical Trials Database - Free Access to 476 Studies
Access comprehensive clinical trial information for Amyotrophic Lateral Sclerosis through Pure Global AI's free database. This collection includes 476 clinical trials across multiple phases including N/A, Phase 2, Phase 1. Currently, 105 trials are actively recruiting participants.
Research for Amyotrophic Lateral Sclerosis is being conducted in United States of America, France, China and 7+ other countries. Leading sponsors include Peking University Third Hospital and Cytokinetics. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Patients' and Caregivers' Views of Multidimensional Care in Amyotropic Lateral Sclerosis in Germany
Personalized Antisense Oligonucleotide Therapy for A Single Participant With CHCHD10 ALS
ALS Phase II Study of NX210c
Neural Stem Cell Treatment for Amyotrophic Lateral Sclerosis (STEMALS)
Perception of Unpleasant Sensations During Study Procedures in ALS Patients
Nerve Growth Factor Encapsulated With 2-methacryloyloxyethyl Phosphorylcholine Nanocapsules in the Treatment of Amyotrophic Lateral Sclerosis
Ultra-high-caloric, Fatty Diet in ALS
Evaluating Verbal Communication in Structured Interactions: Theoretical and Clinical Implications
A Study to Assess the Safety, Tolerability, and Pharmacology of Darifenacin in Patients With ALS
DIAGALS: Relation Between Tar DNA Binding Protein(TDP)-43 et Nrf-2 in ALS: a Track to Improve Diagnosis and Prognosis of the Disease
Contralateral R1 in Amyotrophic Lateral Sclerosis
Reinnervation and Neuromuscular Transmission in ALS
Study in ALS With Abatacept & IL-2
A Study of VRG50635 in Participants With Amyotrophic Lateral Sclerosis (ALS)
Holter of Movement in Patients With Amyotrophic Lateral Sclerosis.
Trial on the Biological and Clinical Effects of Acetyl-L-carnitine in ALS
Safety, Tolerability, and Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Amyotrophic Lateral Sclerosis (ALS) Patients With SOD1 Mutations
Development of Targeted RNA-Seq for Amyotrophic Lateral Sclerosis Diagnosis
Pridopidine in Amyotrophic Lateral Sclerosis (EAP 2)
Remote Home Assessment of Patients With Amyotrophic Lateral Sclerosis
Pure Global AI provides free access to 476 clinical trials studying Amyotrophic Lateral Sclerosis, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Peking University Third Hospital, Cytokinetics, University of Michigan, among others.